CVR number 10607280
Industry 32.5000 Manufacture of medical and dental instruments and supplies

Wallin A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  14.3% 5.4% 8.9% 9.5% 13.0%  
Credit score (0-100)  16 41 26 25 17  
Credit rating  BB BBB BB BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  -844 611 288 570 434  
EBITDA  -1,496 -42.0 -400 -104 -160  
EBIT  -1,550 -97.0 -555 -247 -160  
Pre-tax profit (PTP)  -1,755.0 -345.0 -786.0 -530.0 -485.2  
Net earnings  -1,640.0 -225.0 -609.0 -456.0 -272.6  
Pre-tax profit without non-rec. items  -1,755 -345 -786 -530 -485  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  352 298 143 0.0 0.0  
Shareholders equity total  -2,704 -2,929 -3,537 -3,994 -4,266  
Interest-bearing liabilities  4,063 3,900 4,304 5,133 5,276  
Balance sheet total (assets)  1,538 1,513 1,142 1,432 1,247  
Net Debt  3,867 3,565 4,204 5,102 5,098  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -844 611 288 570 434  
Gross profit growth  -80.0% 0.0% -52.9% 97.9% -23.9%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,538 1,513 1,142 1,432 1,247  
Balance sheet change%  -25.6% -1.6% -24.5% 25.4% -12.9%  
Added value  -1,496.0 -42.0 -400.0 -92.0 -159.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -109 -109 -310 -286 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  183.6% -15.9% -192.7% -43.3% -36.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -42.0% -2.2% -12.2% -4.9% -2.9%  
ROI %  -44.3% -2.4% -13.2% -5.2% -3.1%  
ROE %  -91.0% -14.7% -45.9% -35.4% -20.4%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  -63.7% -65.9% -75.6% -73.6% -77.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -258.5% -8,488.1% -1,051.0% -4,905.8% -3,187.9%  
Gearing %  -150.3% -133.2% -121.7% -128.5% -123.7%  
Net interest  0 0 0 0 0  
Financing costs %  6.0% 6.2% 5.6% 6.0% 6.3%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  5.1 1.8 1.4 2.6 3.0  
Current Ratio  8.7 2.7 3.4 6.3 7.6  
Cash and cash equivalent  196.0 335.0 100.0 31.0 177.3  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,047.0 771.0 705.0 1,205.0 1,081.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  -1,496 -42 -400 -92 -160  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -1,496 -42 -400 -104 -160  
EBIT / employee  -1,550 -97 -555 -247 -160  
Net earnings / employee  -1,640 -225 -609 -456 -273